How Should Functionally Equivalent Drugs be Reimbursed? Panos G. KanavosÖmer R. Saka Practical Disease Management 07 October 2012 Pages: 359 - 370
Efficiency of Interventions in HIV Infection, 1994–2004 Guy HarlingRobin WoodEduard J. Beck Review Article 07 October 2012 Pages: 371 - 394
Education and Phone Follow-Up in Postmenopausal Women at Risk for Osteoporosis John T. SchousboeRowan C. DeBoldThomas A. Abbott III Original Research Article 07 October 2012 Pages: 395 - 404
Utilization and Medical Care Expenditures in Patients with Chronic Obstructive Pulmonary Disease Kristina S. Yu-IsenbergAnn VanderplasHemal Shah Original Research Article 07 October 2012 Pages: 405 - 412
Consumer Knowledge of the Impact of a Change in Prescription Drug Benefit Design Roger FeldmanJean AbrahamCaroline Carlin Original Research Article 07 October 2012 Pages: 413 - 420
Cost Effectiveness of a Clinical Decision Support System Based on the Recommendations of the European Society of Cardiology and Other Societies for the Management of Hypercholesterolemia Albert CobosJordi VilasecaSalvador Bergoñón Original Research Article 07 October 2012 Pages: 421 - 432